References
- London NJ, Farmery SM, Will EJ, Davison AM, Lodge JP: Risk of neoplasia in renal transplant patients. Lancet. 1995;346:403-406 https://doi.org/10.1016/S0140-6736(95)92780-8
- Veroux M, Puliatti C, Fiamingo P, et al: Early de novo malignancies after kidney transplantation. Transplant Proc. 2004;36: 718-720 https://doi.org/10.1016/j.transproceed.2004.03.021
- Kasiske BL, Snyder JJ, Gilbertson DT, Wang C: Cancer after kidney transplantation in the United States. Am J Transplant. 2004;4:905-913 https://doi.org/10.1111/j.1600-6143.2004.00450.x
- Brunner FP, Landais P, Selwood NH: Malignancies after renal transplantation: the EDTA-ERA registry experience. European Dialysis and Transplantation Association-European Renal Association. Nephrol Dial Transplant. 1995;10:74-80
- Fahey TJ 3rd, Reeve TS, Delbridge L: Increasing incidence and changing presentation of thyroid cancer over a 30-year period. Br J Surg. 1995;82:518-520 https://doi.org/10.1002/bjs.1800820426
- Franceschi S, La Vecchia C: Thyroid cancer. Cancer Surv. 1994; 19-20:393-422
- Nemes B, Zalatnai A, Podder H, et al: Papillary microcarcinoma of the thyroid gland in renal transplant patients. Pathol Oncol Res. 2000;6:72-75 https://doi.org/10.1007/BF03032662
- Korea Central Cancer Registry Working Group: Korea Cancer Statistics: 1996 Incidence. Seoul. GA: Department of Disease Control and Prevention Services. National Health Insurance Cooperation and Nation Cancer Institute, 2004.Korean cancer Survellence, 2007:1190
- Shah JP: AJCC Cancer Staging Handbook. TNM classification of malignant tumors, 6th ed. In: Greene FL(ed) Springer-Verlag, New York, 2002:77-78
- Keast D: Immunosurveillance and cancer. Lancet. 1970;2:710-712
- Schwartz RS: Immunoregulation, oncogenic viruses, and malignant lymphomas. Lancet. 1972;1:1266-1269
- Suzuki T, Takano Y, Yamashita K, Sato K, Kakita A, Okudaira M: A possible role for Epstein-Barr virus in tumorigenesis after immunosuppression in cases of renal transplantation. J Cancer Res Clin Oncol. 1993:119:627-629 https://doi.org/10.1007/BF01372727
- Penn I: Cancers following cyclosporine therapy. Transplantation. 1987;43:32-35 https://doi.org/10.1097/00007890-198701000-00008
- Penn I: Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet. 1986;162:603-610
- First MR, Peddi VR: Malignancies complicating organ transplantation. Transplant Proc. 1998;30:2768-2770 https://doi.org/10.1016/S0041-1345(98)00805-7
- Nafar M, Einollahi B, Hemati K, Gholi FP, Firouzan A: Development of malignancy following living donor kidney transplantation. Transplant Proc. 2005;37:3065-3067 https://doi.org/10.1016/j.transproceed.2005.08.011
- Wang CX, Liu LS, Chen LZ, et al: Characteristics of neoplasm occurrence and the therapeutic effect of Sirolimus in South Chinese kidney transplant recipients. Transplant Proc. 2006;38:3536-3539 https://doi.org/10.1016/j.transproceed.2006.10.070
- Pond F, Serpell JW, Webster A: Thyroid cancer in the renal transplant population: epidemiological study. ANZ J Surg. 2005; 75:106-109 https://doi.org/10.1111/j.1445-2197.2005.03311.x
- Samhan M, Al-Mousawi M, Donia F, Fathi T, Nasim J, Nampoory MR: Malignancy in renal recipients. Transplant Proc. 2005;37:3068-3070 https://doi.org/10.1016/j.transproceed.2005.07.046
- Hoshida Y, Aozasa K: Malignancies in organ transplant recipients. Pathol Int. 2004;52:649-658